These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 8667035

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W, Chylak J, Pietkiewicz K.
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP, Pottumarthy S, Morris AJ.
    N Z Med J; 1999 Nov 12; 112(1099):424-6. PubMed ID: 10678225
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC, Martínez-Brocal A, Miranda C, Rojo MD, García V, Domínguez MC, de la Rosa M.
    Enferm Infecc Microbiol Clin; 1991 Apr 12; 9(4):219-22. PubMed ID: 1863621
    [Abstract] [Full Text] [Related]

  • 30. Comparative in vitro activity of PH-027 versus linezolid and other anti-anaerobic antimicrobials against clinical isolates of Clostridium difficile and other anaerobic bacteria.
    Phillips OA, Rotimi VO, Jamal WY, Shahin M, Verghese TL.
    J Chemother; 2003 Apr 12; 15(2):113-7. PubMed ID: 12797385
    [Abstract] [Full Text] [Related]

  • 31. [Study of obligate anaerobic bacterial sensitivity to tinidazole and metronidazole (determination of minimal inhibiting concentration--MIC)].
    Kałowski M, Dybicki J, Kedzia A, Lukiański M.
    Wiad Lek; 1993 Mar 12; 46(5-6):211-5. PubMed ID: 8249400
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA, García-Sánchez JE, Trujillano-Martín I, García-Sánchez E, García-García MI, Fresnadillo-Martínez MJ.
    J Chemother; 1995 Jun 12; 7(3):189-96. PubMed ID: 7562012
    [Abstract] [Full Text] [Related]

  • 37. [Activity of fusidic acid on strictly anaerobic bacteria].
    Canzi AM, Weber P, Boussougant Y.
    Pathol Biol (Paris); 1987 May 12; 35(5):577-80. PubMed ID: 3302863
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ.
    J Antimicrob Chemother; 2006 May 12; 57(5):992-8. PubMed ID: 16507560
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods.
    Ednie LM, Credito KL, Khantipong M, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 2000 May 12; 45(5):633-8. PubMed ID: 10797085
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.